Clinical trial
Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally…
NCT00024310 · Jonsson Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00024310 |
|---|---|
| Title | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors |
| Official title | A Phase I Trial of Lometrexol Sodium and Paclitaxel Adminsitered Intravenously Every 21 Days in Conjunction With Oral Folic Acid in Patients With Solid Tumors |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement, Drug |
| Interventions | folic acid, lometrexol, paclitaxel |
| Start date | Sep 1, 2001 |
| First posted | Jun 20, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: